Recombinant Product Laboratory

Recombinant Product Laboratory (RPL ), a CDL notified and NABL accredited Lab contributes to the Regulatory functions of recombinant bio therapeutic products under the class of: Insulin, Insulin Analogs, Growth Factors , Cytokines and Peptides. These products are intended for therapeutic indications for the treatment of diabetes (Type 1 and Type 2), viral hepatitis, chronic kidney disease, cancer, osteoporosis.The QC testing of the pharmacopoeial products are carried out as per current version of Indian Pharmacopoeia and as per manufacturer's protocol for Non Pharmacopoeial products.